B9JEX8 UDP-3-O-acylglucosamine N-acyltransferase MolNFT, Molecular NFT on GenesisL1

UDP-3-O-acylglucosamine N-acyltransferase

MOLNFT AF v1 smart contract in GenesisL1 blockchain:

0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD

IPFS of NFT metadata:

bafybeidtfrrbxsljgxl4da54vb3m7onrjfq5sg5zrmycparlg5wunfzxzy/metadata.json

IPFS of structure file:

bafybeidvmsiut775tfejb4kf7tdvo2nu6dauqfj6vhms2w4mz56sv5tbqy/AF-B9JEX8-F1-model_v2.pdb

First NFT owner address (eip-55):

0x4bC225Cd2778aD8b434c09FeFE8BcBb702fea729

First NFT owner address (bech32):

genesis1f0pztnf80zkcks6vp8l0az7tkup0afefmk9lmj

Current NFT ID #218698 owner (web3):

0xFE12884Eff419603b6dFefe423f9b5276dad6aD4

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
218698
Accession (UniProt):
B9JEX8
Name::
UDP-3-O-acylglucosamine N-acyltransferase
Experimental Method:
Predicted structure
Sequence source:
AGROBACTERIUM RADIOBACTER (STRAIN K84 / ATCC BAA-868)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B9JEX8 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B9JEX8|LPXD_AGRRK UDP-3-O-acylglucosamine N-acyltransferase OS=Agrobacterium radiobacter (strain K84 / ATCC BAA-868) OX=311403 GN=lpxD PE=3 SV=1 MEHIGFFPPHDGVSLRALAEHLGAELADEAFAGVIIKSIAPVYRAGDGDVCYLLSRKNRAELETCKASAIICLPTLSSLVPEHIPVLLSKKPHTDFALAGALLHPQAMRPVALTSTPTLISPTAFVDPTAKLEADVGVEPGAVVGPGAEIGEGTRIGAGAIIGPGVKIGRHCTIGGGASVLCSYLGNGVIIHNGARIGQDGFGYAPSPRGMIKIVQIGRVIIQDNVEIGANTTIDRGTMDDTVIGEGTKIDNQVQIGHNVRIGRYCAIVSQVGIAGSAVIGDGVQIGGHTGINGHIQIGDGVQIGAMSGVMNSIPAGERFAGIPARPLWDFLREAAEVAKRSGAREKKDGSAEHD

B9JEX8 AF NFT

MOLNFT AF v1

NFT data

MOLNFT B9JEX8 research and analysis (ICN3D with VR)

FASTA sequences

We use cookies on this site to enhance your user experience